Methods of rapid diagnosis for the etiology of meningitis in adults

Biomarkers in Medicine

Volumn 8, Issue 9, 2014, Pages 1085-1103

  Bahr, Nathan C ^a,b   Boulware, David R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Aseptic meningitis; Bacterial meningitis; Cryptococcus meningitis; Diagnosis; Diagnostic tests; Tuberculosis meningitis

Indexed keywords

C REACTIVE PROTEIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; PROCALCITONIN;

ALCOHOLISM; ANTIGEN DETECTION; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BLOOD CULTURE; CHEMOTHERAPY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC MENINGITIS; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS MENINGITIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LATERAL FLOW IMMUNOCHROMATOGRAPHIC ASSAY; LIPOARABINOMANN ANANTIGEN DETECTION TEST; LISTERIA MONOCYTOGENES; MENINGITIS; MORBIDITY; MORTALITY; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PNEUMOCOCCAL MENINGITIS; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; STAINING; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; TUBERCULOUS MENINGITIS; VACCINATION; VARICELLA ZOSTER VIRUS; ZIEHL NEELSEN STAINING; ADULT; BLOOD; FEMALE; MALE; MENINGITIS, BACTERIAL; MENINGITIS, CRYPTOCOCCAL; MOLECULAR DIAGNOSIS; PROCEDURES;

BACTERIA (MICROORGANISMS);

ADULT; FEMALE; HUMANS; MALE; MENINGITIS, BACTERIAL; MENINGITIS, CRYPTOCOCCAL; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES;

EID: 84911468389     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/BMM.14.67     Document Type: Review

References (119)

1. Bhimraj A. Acute community-acquired bacterial meningitis in adults: an evidence-based review. Cleve. Clin. J. Med. 79(6), 393-400 (2012).
2. Brouwer MC, Thwaites GE, Tunkel AR, van de Beek D. Dilemmas in the diagnosis of acute community-acquired bacterial meningitis. Lancet 380(9854), 1684-1692 (2012).
3. Ersoy Y, Yetkin F, Bayraktar MR, Ersoy Y, Yologlu S. A new diagnostic scoring for discrimination of tuberculous and bacterial meningitis on the basis of clinical and laboratory findings. Med. Princ. Pract. 21(3), 259-263 (2012).
4. Thigpen MC, Whitney CG, Messonnier NE et al. Bacterial meningitis in the United States, 1998-2007. N. Engl. J. Med. 364(21), 2016-2025 (2011).
5. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin. Microbiol. Rev. 23(3), 467-492 (2010).
6. Tuppeny M. Viral meningitis and encephalitis. Crit. Care Nurs. Clin. North Am. 25(3), 363-380 (2013).
7. James SH, Kimberlin DW, Whitley RJ. Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res. 83(3), 207-213 (2009).
8. Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol. 12(10), 999-1010 (2013).
9. Rajasingham R, Rolfes MA, Birkenkamp KE, Meya DB, Boulware DR. Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis. PLoS Med. 9(9), e1001316 (2012).
10. Marais S, Pepper DJ, Schutz C, Wilkinson RJ, Meintjes G. Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. PLoS ONE 6(5), e20077 (2011).
11. Cohn AC, MacNeil JR, Harrison LH et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin. Infect. Dis. 50(2), 184-191 (2010).
12. Hsu HE, Shutt KA, Moore MR et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. J. Med. 360(3), 244-256 (2009).
13. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect. Dis. 11(10), 760-768 (2011).
14. National Institute for Communicable Diseases. Group for enteric, respiratory and meningeal disease surveillance in South Africa. In: GERMS-SA Annual Report 2012. Meiring, S, Quan, V, Govender, N, Crowther-Gibson, P (Eds). Johannesburg, South Africa (2012).
15. Gessner BD, Mueller JE, Yaro S. African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infect. Dis. 10, 22 (2010).
16. McIntyre PB, O'Brien KL, Greenwood B, van de Beek D. Effect of vaccines on bacterial meningitis worldwide. Lancet 380(9854), 1703-1711 (2012).
17. Coulson GB, von Gottberg A, du Plessis M et al. Meningococcal disease in South Africa, 1999-2002. Emerg. Infect. Dis. 13(2), 273-281 (2007).
18. Mohammed I, Nasidi A, Alkali AS et al. A severe epidemic of meningococcal meningitis in Nigeria, 1996. Trans. R. Soc. Trop. Med. Hyg. 94(3), 265-270 (2000).
19. Daugla DM, Gami JP, Gamougam K et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet 383(9911), 40-47 (2014).
20. Zipursky S, Djingarey MH, Lodjo J-C, Olodo L, Tiendrebeogo S, Ronveaux O. Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin. Vaccine 32(13), 1431-1435 (2014).
21. Ladhani S, Slack MP, Heys M, White J, Ramsay ME. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch. Dis. Child. 93(8), 665-669 (2008).
22. Schrag SJ, Zywicki S, Farley MM et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342(1), 15-20 (2000).
23. Phares CR, Lynfield R, Farley MM et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299(17), 2056-2065 (2008).
24. World Health Organisation. Global Tuberculosis Report - 2012. 1-6 (2012).
25. Riddell JT, Shuman EK. Epidemiol. Centr. Nerv. Syst. Infect. Neuroimag. Clin. N. Am. 22(4), 543-556 (2012).
26. Berenguer J, Moreno S, Laguna F et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N. Engl. J. Med 326(10), 668-672 (1992).
27. Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, Harrison TS. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect. Dis. 10, 67 (2010).
28. Woldeamanuel YW, Girma B. A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa. J. Neurol. 261(5), 851-865 (2013).
29. CDC. Emergence of Cryptococcus gattii - Pacific Northwest, 2004-2010. Morbid. Mortal. Wkly. Rep. 59(28), 865-868 (2010).
30. Ecevit IZ, Clancy CJ, Schmalfuss IM, Nguyen MH. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin. Infect. Dis. 42(10), 1443-1447 (2006).
31. Loyse A, Wilson D, Meintjes G et al. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. Clin. Infect. Dis. 54(1), 121-128 (2012).
32. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23(4), 525-530 (2009).
33. Cohen DB, Zijlstra EE, Mukaka M et al. Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African setting. Trop. Med. Int. Health 15(8), 910-917 (2010).
34. National Institute for Communicable Diseases. Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA). In: GERMS-SA Annual Report 2011. Govender N, Quan V (Eds). Johannesburg, South Africa (2011).
35. Smith RM, Schaefer MK, Kainer MA et al. Fungal infections associated with contaminated methylprednisolone injections. N. Engl. J. Med. 369(17), 1598-1609 (2013).
36. Johnson RH, Einstein HE. Coccidioidal meningitis. Clin. Infect. Dis. 42(1), 103-107 (2006).
37. Bariola JR, Perry P, Pappas PG et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin. Infect. Dis. 50(6), 797-804 (2010).
38. Wheat LJ, Batteiger BE, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. Clin. Rev. Med. 69(4), 244-260 (1990).
39. Rotbart HA, Brennan PJ, Fife KH et al. Enterovirus meningitis in adults. Clin. Infect. Dis. 27(4), 896-898 (1998).
40. Kupila L, Vuorinen T, Vainionpaa R, Hukkanen V, Marttila RJ, Kotilainen P. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 66(1), 75-80 (2006).
41. Lee BE, Davies HD. Aseptic meningitis. Curr. Opin. Infect. Dis. 20(3), 272-277 (2007).
42. Soares CN, Cabral-Castro MJ, Peralta JM, de Freitas MR, Zalis M, Puccioni-Sohler M. Review of the etiologies of viral meningitis and encephalitis in a dengue endemic region. J. Neurol. Sci. 303(1-2), 75-79 (2011).
43. Rajasingham R, Meya DB, Boulware DR. Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care. J. Acquire. Immune Defic. Syndr. 59(5), e85-e91 (2012).
44. Thwaites GE. Advances in the diagnosis and treatment of tuberculous meningitis. Curr. Opin. Neurol. 26(3), 295-300 (2013).
45. Bekondi C, Bernede C, Passone N et al. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int. J. Infect. Dis. 10(5), 387-395 (2006).
46. Domingo P, Suarez-Lozano I, Torres F et al. Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy. J. Acq. Immune Defic. Syndr. 51(5), 582-587 (2009).
47. Durski KN, Kuntz KM, Yasukawa K, Virnig BA, Meya DB, Boulware DR. Cost-effective diagnostic checklists for meningitis in resource-limited settings. J. Acq. Immune Defic. Syndr. 63(3), e101-e108 (2013).
48. Bahr N, Boulware DR, Marais S, Scriven J, Wilkinson RJ, Meintjes G. Central nervous system immune reconstitution inflammatory syndrome. Curr. Infect. Dis. Rep. 15(6), 583-593 (2013).
49. + cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. Clin. Infect. Dis. 51(4), 448-455 (2010).
50. Newland A, Provan D, Myint S. Preventing severe infection after splenectomy. BMJ 331(7514), 417-418 (2005).
51. Adriani KS, Brouwer MC, van der Ende A, van de Beek D. Bacterial meningitis in adults after splenectomy and hyposplenic states. Mayo Clin. Proc. 88(6), 571-578 (2013).
52. Martinot M, Oswald L, Parisi E et al. Immunoglobulin deficiency in patients with Streptococcus pneumoniae or Haemophilus influenzae invasive infections. Int. J. Infect. Dis. 19, 79-84 (2014).
53. Domingo P, Barquet N, Alvarez M, Coll P, Nava J, Garau J. Group B streptococcal meningitis in adults: report of twelve cases and review. Clin. Infect. Dis. 25(5), 1180-1187 (1997).
54. Brouwer MC, van de Beek D, Heckenberg SG, Spanjaard L, de Gans J. Community-acquired Listeria monocytogenes meningitis in adults. Clin. Infect. Dis. 43(10), 1233-1238 (2006).
55. Cabellos C, Viladrich PF, Ariza J, Maiques JM, Verdaguer R, Gudiol F. Community-acquired bacterial meningitis in cirrhotic patients. Clin. Microbiol. Infect. 14(1), 35-40 (2008).
56. Castro Marquez C, Castro Laria L, Arguelles Arias F, Herrerias JM. Residual hydrocephalus after tuberculous meningitis in a patient with biological therapy. Inflamm. Bowel Dis. 17(6), E33-E34 (2011).
57. Girardi K, Paviglianiti A, Cirillo M et al. Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission. J. Clin. Exp. Hematopathol. 52(1), 31-34 (2012).
58. Petramfar P, Yousefian M, Ashraf MH, Davarpanah MA, Rahmati H. Meningoencephalitis with Aspergillus and Mycobacterium tuberculosis in a renal transplant recipient. Exp. Clin. Transplant. 9(1), 68-71 (2011).
59. Perfect JR, Dismukes WE, Dromer F et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin. Infect. Dis. 50(3), 291-322 (2010).
60. Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N. Engl. J. Med. 317(6), 334-341 (1987).
61. Sethi NK, Torgovnick J, Sethi PK. Cryptococcal meningitis after Imuran (azathioprine) therapy for autoimmune hepatitis. Eur. J. Gastroenterol. Hepatol. 19(10), 913-914 (2007).
62. Schmidt-Hieber M, Schwender J, Heinz WJ et al. Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents. Haematologica 96(1), 142-149 (2011).
63. Patel VB, Theron G, Lenders L et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med. 10(10), e1001536 (2013).
64. Nhu NT, Heemskerk D, Thu do DA et al. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J. Clin. Microbiol. 52(1), 226-233 (2014).
65. Thwaites GE, Chau TT, Stepniewska K et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 360(9342), 1287-1292 (2002).
66. Amaya-Villar R, Garcia-Cabrera E, Sulleiro-Igual E et al. Three-year multicenter surveillance of community-acquired listeria monocytogenes meningitis in adults. BMC Infect. Dis. 10, 324 (2010).
67. Ray P, Badarou-Acossi G, Viallon A et al. Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear. Am. J. Emerg. Med 25(2), 179-184 (2007).
68. Kambugu A, Meya DB, Rhein J et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin. Infect. Dis. 46(11), 1694-1701 (2008).
69. Day JN, Chau TT, Lalloo DG. Combination antifungal therapy for cryptococcal meningitis. N. Engl. J. Med, 368(26), 2522-2523 (2013).
70. Mohan S, Jain KK, Arabi M, Shah GV. Imaging of meningitis and ventriculitis. Neuroimaging Clin. N. Am. 22(4), 557-583 (2012).
71. Helbok R, Pongpakdee S, Yenjun S et al. Chronic meningitis in Thailand. Clinical characteristics, laboratory data and outcome in patients with specific reference to tuberculosis and cryptococcosis. Neuroepidemiology 26(1), 37-44 (2006).
72. Hakim JG, Gangaidzo IT, Heyderman RS et al. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. Aids 14(10), 1401-1407 (2000).
73. Boulware DR, Bonham SC, Meya DB et al. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J. Infect. Dis. 202(6), 962-970 (2010).
74. Altun O, Almuhayawi M, Ullberg M, Ozenci V. Clinical evaluation of the filmarray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J. Clin. Microbiol. 51(12), 4130-4136 (2013).
75. Ruggiero P, McMillen T, Tang YW, Babady NE. Evaluation of the BioFire FilmArray respiratory panel and the GenMark eSensor respiratory viral panel on lower respiratory tract specimens. J. Clin. Microbiol. 52(1), 288-290 (2014).
76. Rath PM, Schoch B, Adamzik M, Steinmann E, Buer J, Steinmann J. Value of multiplex PCR using cerebrospinal fluid for the diagnosis of ventriculostomy-related meningitis in neurosurgery patients. Infection 42(4), 621-627 (2014).
77. Biofire Diagnostics I. FilmArray Meningitis/Encephalitis Panel. http://filmarray.com
78. Boulware DR, Rolfes MA, Rajasingham R et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg. Infect. Dis. 20(1), 45-53 (2014).
79. Kabanda T, Siedner MJ, Klausner JD, Muzoora C, Boulware DR. Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. Clin. Infect. Dis. 58(1), 113-116 (2014).
80. Lindsley MD, Mekha N, Baggett HC et al. Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin. Infect. Dis. 53(4), 321-325 (2011).
81. Jarvis JN, Percival A, Bauman S et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin. Infect. Dis. 53(10), 1019-1023 (2011).
82. Hansen J, Slechta ES, Gates-Hollingsworth MA et al. Largescale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid. Clin. Vaccine Immunol. 20(1), 52-55 (2013).
83. Musubire AK, Boulware DR, Meya DB, Rhein J. Diagnosis and management of Cryptococcal relapse. J. AIDS Clin. Res. (Suppl. 3 (3)), pii: S3-S003 (2013).
84. Brouwer AE, Teparrukkul P, Pinpraphaporn S et al. Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis. J. Infect. Dis. 192(4), 681-684 (2005).
85. Chang CC, Lim A, Omarjee S et al. Cryptococcosis-IRIS is associated with lower Cryptococcus-specific IFN-gamma responses before antiretroviral therapy but not higher T-cell responses during therapy. J. Infect. Dis. 208(6), 898-906 (2013).
86. Wheat LJ, Kohler RB, Tewari RP, Garten M, French ML. Significance of Histoplasma antigen in the cerebrospinal fluid of patients with meningitis. Arch. Intern. Med. 149(2), 302-304 (1989).
87. Litvintseva AP, Lindsley MD, Gade L et al. Utility of (1-3)-beta-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin. Infect. Dis. 58(5), 622-630 (2014).
88. Mikulska M, Furfaro E, Del Bono V et al. (1-3)-beta-D-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. Clin. Infect. Dis. 56(10), 1511-1512 (2013).
89. Marais S, Thwaites G, Schoeman JF et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect. Dis. 10(11), 803-812 (2010).
90. Patel VB, Singh R, Connolly C et al. Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting. PLoS ONE 5(12), e15664 (2010).
91. Ho J, Marais BJ, Gilbert GL, Ralph AP. Diagnosing tuberculous meningitis - have we made any progress? Trop. Med. Int. Health 18(6), 783-793 (2013).
92. Feng GD, Shi M, Ma L et al. Diagnostic Accuracy of intracellular mycobacterium tuberculosis detection for tuberculous meningitis. Am. J. Respir. Crit. Care Med.189(4), 475-481 (2014).
93. Huang Z, Xiong G, Luo Q et al. Evaluation of the performance of the microscopic observation drug susceptibility assay for diagnosis of extrapulmonary tuberculosis in China: a preliminary study. Respirology 19(1), 132-137 (2014).
94. Caws M, Dang TM, Torok E et al. Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis. PLoS ONE 2(11), e1173 (2007).
95. Xu HB, Jiang RH, Li L, Sha W, Xiao HP. Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis: a meta-analysis. Int. J. Tuberc. Lung Dis. 14(11), 1382-1387 (2010).
96. Park KH, Cho OH, Lee EM, et al. T-cell-based assays on cerebrospinal fluid andPBMCs for rapid diagnosis of TB meningitis in non-HIV patients. Eur. Resp. J.. 39(3), 768-770 (2012).
97. Kim SH, Cho OH, Park SJ et al. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin. Infect. Dis. 50(10), 1349-1358 (2010).
98. Patel VB, Singh R, Connolly C et al. Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am. J. Respir. Crit. Care Med. 182(4), 569-577 (2010).
99. Sardella IG, Singh M, Kumpfer S, Heringer RR, Saad MH, Sohler MP. Evaluation of Lionex TB kits and mycobacterial antigens for IgG and IgA detection in cerebrospinal fluid from tuberculosis meningitis patients. Mem. Inst. Oswaldo Cruz105(5), 722-728 (2010).
100. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM Jr. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect. Dis. 3(10), 633-643 (2003).
101. Solomons RS, van Elsland SL, Visser DH et al. Commercial nucleic acid amplification tests in tuberculous meningitis - a meta-analysis. Diagn. Microbiol. Infect. Dis.78(4), 398-403 (2014).
102. Nagdev KJ, Kashyap RS, Parida MM et al. Loop-mediated isothermal amplification for rapid and reliable diagnosis of tuberculous meningitis. J. Clin. Microbiol. 49(5), 1861-1865 (2011).
103. Tortoli E, Russo C, Piersimoni C et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur. Respir. J. 40(2), 442-447 (2012).
104. Causse M, Ruiz P, Gutierrez-Aroca JB, Casal M. Comparison of two molecular methods for rapid diagnosis of extrapulmonary tuberculosis. J. Clin. Microbiol. 49(8), 3065-3067 (2011).
105. Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J. Clin. Microbiol. 49(7), 2540-2545 (2011).
106. Boulware DR. Utility of the Xpert MTB/RIF assay for diagnosis of tuberculous meningitis. PLoS Med. 10(10), e1001537 (2013).
107. Viallon A, Zeni F, Lambert C et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin. Infect. Dis. 28(6), 1313-1316 (1999).
108. Boisier P, Mahamane AE, Hamidou AA et al. Field evaluation of rapid diagnostic tests for meningococcal meningitis in Niger. Trop. Med. Int. Health 14(1), 111-117 (2009).
109. Moisi JC, Saha SK, Falade AG et al. Enhanced diagnosis of pneumococcal meningitis with use of the Binax NOW immunochromatographic test of Streptococcus pneumoniae antigen: a multisite study. Clin. Infect. Dis. 48(Suppl. 2), S49-S56 (2009).
110. Rose AM, Mueller JE, Gerstl S et al. Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007. PLoS ONE 5(6), e11086 (2010).
111. Sakushima K, Hayashino Y, Kawaguchi T, Jackson JL, Fukuhara S. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J. Infect. 62(4), 255-262 (2011).
112. Srinivasan L, Pisapia JM, Shah SS, Halpern CH, Harris MC. Can broad-range 16S ribosomal ribonucleic acid gene polymerase chain reactions improve the diagnosis of bacterial meningitis? A systematic review and meta-analysis. Ann. Emerg. Med. 60(5), 609-620 e602 (2012).
113. Kim DW, Kilgore PE, Kim EJ, Kim SA, Anh DD, Seki M. Loop-mediated isothermal amplification assay for detection of Haemophilus influenzae type b in cerebrospinal fluid. J. Clin. Microbiol. 49(10), 3621-3626 (2011).
114. Kim DW, Kilgore PE, Kim EJ et al. The enhanced pneumococcal LAMP assay: a clinical tool for the diagnosis of meningitis due to Streptococcus pneumoniae. PLoS ONE 7(8), e42954 (2012).
115. Meyler KL, Meehan M, Bennett D, Cunney R, Cafferkey M. Development of a diagnostic real-time polymerase chain reaction assay for the detection of invasive Haemophilus influenzae in clinical samples. Diagn. Microbiol. Infect. Dis. 74(4), 356-362 (2012).
116. Le Monnier A, Abachin E, Beretti JL, Berche P, Kayal S. Diagnosis of Listeria monocytogenes meningoencephalitis by real-time PCR for the hly gene. J. Clin. Microbiol. 49(11), 3917-3923 (2011).
117. Volle R, Nourrisson C, Mirand A et al. Quantitative real-time RT-PCR assay for research studies on enterovirus infections in the central nervous system. J. Virol. Meth. 185(1), 142-148 (2012).
118. Ninove L, Nougairede A, Gazin C et al. Comparative detection of enterovirus RNA in cerebrospinal fluid: GeneXpert system vs. real-time RT-PCR assay. Clin. Microbiol. Infect. 17(12), 1890-1894 (2011).
119. Zarrouk V, Leflon-Guibout V, Robineaux S et al. Broad-range 16S rRNA PCR with cerebrospinal fluid may be unreliable for management of postoperative aseptic meningitis. J. Clin. Microbiol. 48(9), 3331-3333 (2010).